Tofatas-XR Tablet
Prescription required
Highlights
description
A powerful Janus Kinase (JAK) inhibitor used to manage moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It helps reduce joint pain, swelling, and inflammation to restore mobility.
key benefits
Sustained management of moderate to severe rheumatoid arthritis
side effects
Upper respiratory tract infections, headache, diarrhea, or high blood pressure.
alcohol interaction
Caution
pregnancy interaction
Consult Your Doctor
lactation interaction
Consult Your Doctor
driving interaction
Safe
kidney interaction
Caution
liver interaction
Caution
Information
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship.
While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
customer care details
In case of any issue, contact us
E-mail address: support@zeptonow.com
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited, Unit 508, Sakti Statesman, 5th floor, Green Glen Layout, No.37/301/34/1, SY.NO.34, Ibblur Village, Begur Hobli, Bangalore, Karnataka-560103
Pharmacy License No.
KA-B61-283317, KA-B61-283318
Manufacturer or Marketer Address
Bagheykhola, Majitar, Sikkim - 737136, India
Country of Origin
India
Manufacturer or Marketer Name
Intas Pharmaceuticals Limited
Shelf Life
24 months
Expires on or after
December 2026
